Fracture risk and zoledronic acid in men with osteoporosis. [electronic resource]
- The New England journal of medicine 02 2013
- 872-3 p. digital
Publication Type: Letter; Comment
1533-4406
10.1056/NEJMc1214992 doi
Bone Density Conservation Agents--therapeutic use Diphosphonates--therapeutic use Humans Imidazoles--therapeutic use Male Osteoporosis--drug therapy Spinal Fractures--prevention & control